Join
Live feed
·
PRReleasevia Quantisnow
VYNE Therapeutics Inc. logo

VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience

ByQuantisnow·Wall Street's wire, on your screen.
VYNE· VYNE Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VYNE (VYNE Therapeutics Inc.) and more on Quantisnow.